Enhanced level of the complement proteins such as C9,15 complement component 4 binding protein alpha and beta (C4BPA and C4BPB)13,32 was previously reported in CRC patients while increased C1QB is novel. This evidence concerns the gene C4BPA and colorectal carcinoma.